Cautious Outlook on Oscar Health: Sell Rating Amid Uncertain Profitability and Market Dynamics
I'm PortAI, I can summarize articles.
Analyst Stephen Baxter of Wells Fargo has maintained a Sell rating on Oscar Health, lowering the price target to $11.00 due to concerns over the company's profitability and market dynamics. Despite potential market share gains in 2026, uncertainties regarding the medical loss ratio (MLR) and the impact of subsidy expirations contribute to a cautious outlook. UBS also issued a Sell rating with a $12.00 target. Baxter's average return is -2.5% with a 41.81% success rate in the Healthcare sector.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments